MAKO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
|Steven Cohen 2,548 sh (New)|
Jim Simons 1,487,600 sh (+362.71%)
Mario Gabelli 244,900 sh (+13.7%)
|Manning & Napier Advisors, Inc Sold Out|
John Keeley Sold Out
|Steven Cohen 8,200 sh (+221.82%)|
Mario Gabelli 299,700 sh (+22.38%)
|Jim Simons 708,300 sh (-52.39%)|
|Mario Gabelli 706,600 sh (+135.77%)||Steven Cohen Sold Out|
Jim Simons Sold Out
(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
|Guru||Date||Trades||Impact to Portfolio||Price Range * (?)||Current Price||Change from Average||Current Shares|
|Mario Gabelli||2013-12-31||Sold Out||0.12%||$29.55 - $29.99||$ 29.99||0%||0|
|Mario Gabelli||2013-09-30||Add 135.77%||0.07%||$11.61 - $29.5||$ 29.99||99%||706600|
|Mario Gabelli||2013-06-30||Add 22.38%||$10.33 - $12.81||$ 29.99||164%||299700|
|John Keeley||2013-03-31||Sold Out||$10.76 - $13.17||$ 29.99||155%||0|
|John Burbank||2012-12-31||Sold Out||0.12%||$12.09 - $17.78||$ 29.99||109%||0|
|John Keeley||2012-12-31||New Buy||$12.09 - $17.78||$ 29.99||109%||75|
|John Burbank||2012-09-30||New Buy||0.12%||$12.18 - $26.46||$ 29.99||85%||150000|
|Mario Gabelli||2012-09-30||Add 33.68%||0.01%||$12.18 - $26.46||$ 29.99||85%||194900|
|Mario Gabelli||2012-06-30||Add 23.87%||0.01%||$21.37 - $42.5||$ 29.99||-3%||145800|
|Mario Gabelli||2011-09-30||Add 45.31%||0.01%||$21.41 - $40.48||$ 29.99||-9%||83700|
|Mario Gabelli||2011-06-30||New Buy||0.01%||$23.51 - $34.66||$ 29.99||7%||57600|
|George Soros||2011-06-30||Sold Out||$23.51 - $34.66||$ 29.99||7%||0|
|Industry:||Medical Devices » Medical Devices|
|Traded in other countries:||4M6.Germany|
|MAKO Surgical Corporation was incorporated in Delaware in November 2004. The Company is a medical device company that markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures. It offers MAKOplasty, an innovative, restorative surgical solution that enables orthopedic surgeons to consistently, reproducibly and precisely treat patient specific, osteoarthritic disease. The Company currently offers MAKOplasty Partial Knee Arthroplasty, or MAKOplasty PKA, and MAKOplasty Total Hip Arthroplasty, or MAKOplasty THA. MAKOplasty PKA, which requires extraction and replacement of the entire joint, enables resurfacing of one or two specific diseased compartments of the joint, preserving significantly more soft tissue and healthy bone of the knee. MAKOplasty procedures are enabled through its proprietary technology consisting of the components which includes its RIO system, its MAKOplasty applications, and its RESTORIS family of implant systems. The centerpiece of MAKOplasty is the RIO system, its proprietary robotic arm, interactive, orthopedic system, that provides both pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal and accurate implant insertion and alignment. The RIO system consists of two elements: a tactile robotic arm utilizing an integrated bone cutting instrument and a patient specific visualization component. The RIO system, version 2.0 of its Tactile Guidance System, or TGS, represents an important expansion from its first generation TGS, enabling and expanding the MAKOplasty PKA application to multicompartmental resurfacing procedures, allowing orthopedic surgeons to treat degenerative knee osteoarthritis from early-stage, unicompartmental degeneration through mid-stage, multicompartmental degeneration with a modular knee implant system, as well as enabling the MAKOplasty THA application. The Company's MAKOplasty PKA application enables surgeons to isolate and resurface just one or two specific diseased compartments of the joint through a minimally invasive incision, preserving significantly more soft tissue and healthy bone of the knee. The MAKOplasty knee resurfacing procedure is performed by the surgeon using the surgical planning and execution software integrated into its patient specific visualization system. The Company's MAKOplasty THA application utilizes the RIO system's tactile, visual and auditory feedback to assist the surgeon in preparing the acetabulum (hip socket) for optimal placement of the acetabular cup implant. The MAKOplasty THA application allows the surgeon to preoperatively plan the placement of the hip implants on a three dimensional image of a pre-operative CT scan. Its RESTORIS family of knee implants is designed to enable minimally invasive restoration of one or two of the diseased compartments of the knee joint. Its RESTORIS family of knee implants for use in si|
|comment on MAKO Mar 06 2013|
|comment on MAKO Sep 14 2012|
|Companies with Buybacks: ISRG Edition Nov 15 2011|
|MAKO Surgical Corp. Reports Operating Results (10-Q) Nov 03 2010|
|MAKO Surgical Corp. Reports Operating Results (10-Q) Aug 04 2010|
|MAKO Surgical Corp. (MAKO) President, CEO and Chairman Maurice R Ferre sells 10,000 Shares Mar 10 2010|
|MAKO Surgical Corp. (MAKO) President, CEO and Chairman Maurice R Ferre sells 10,000 Shares Jan 14 2010|
|MAKO Surgical Corp. (MAKO) President, CEO and Chairman Maurice R Ferre sells 2,075 Shares Jan 04 2010|
|MAKO Surgical Corp. (MAKO) President, CEO and Chairman Maurice R Ferre sells 7,925 Shares Dec 31 2009|
|MAKO Surgical Corp. (MAKO) President, CEO and Chairman Maurice R Ferre sells 12,000 Shares Dec 16 2009|